As reflected in this application, Mayo Clinic has a long tradition of clinical research and has been a supporter and active participant in the National Clinical Trials Network (NCTN). Support of the NCTN includes formation of one of the founding organizations (North Central Cancer Treatment Group, now Alliance), Sustained leadership roles in the NCTN and in clinical trials, as well as active supporters of clinical trials. Multiple Mayo Clinic staff continue in current leadership roles within the NCTN or NCI sponsored activities related to the NCTN. Mayo Clinic remains committed to making NCTN trials a prominent part of its portfolio of clinical trials for cancer patients or patients at-risk for cancer. This commitment is reflected in the prioritization of NCTN trials over many other trials, the level of accrual to NCTN trials, further refinements to the activation and monitoring of progress of NCTN trials to ensure their success, the continued leadership role of Mayo Clinic physicians in the NCTN member organizations, and an on-going commitment of the MCCC to support this activity. Mayo Clinic physicians and researchers continue to have an active role in not only patient accrual to NCTN clinical trials, but to leadership in developing and leading trials. Mayo Clinic researchers also continue to be active in presenting the results of these trials at national and international meetings and high-impact journals, as described within the current grant application. Mayo Clinic researchers have continued to be active in performing subsequent analyses of the collected data, and meaningful use of the biospecimens collected from the trials to transform the science of cancer care. Mayo Clinic has also continued to focus on the development of junior investigators in the NCTN to ensure the continued active support of NCTN member organizations and the success of NCTN clinical research. Finally, Mayo Clinic is committed to making clinical trials available to all patients, regardless of their racial, ethnicity, or socioeconomic background.

Public Health Relevance

Mayo Clinic has a long tradition of clinical research and has been a supporter and active participant in the National Clinical Trials Network (NCTN). With over 1.3 million unique patients seen each year (of which over 120,000 are patients with cancer), Mayo Clinic is committed to making clinical trials available to all patients regardless of their racial, ethnicity, or socioeconomic background. A major factor in allowing this to occur is through Mayo Clinic's commitment to making NCTN trials a prominent part of its portfolio of clinical trials for cancer patients or patients at-risk for cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Clinical Research Cooperative Agreements - Single Project (UG1)
Project #
5UG1CA232760-02
Application #
9914075
Study Section
Special Emphasis Panel (ZCA1)
Program Officer
Mooney, Margaret M
Project Start
2019-04-12
Project End
2025-02-28
Budget Start
2020-03-01
Budget End
2021-02-28
Support Year
2
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905